Cargando…
Novel piperidine derivatives as colchicine binding site inhibitors induce apoptosis and inhibit epithelial-mesenchymal transition against prostate cancer PC3 cells
Tubulin polymerisation inhibitors that target colchicine binding site were powerful anticancer agents. Although along the years many colchicine binding site inhibitors (CBSIs) have been reported, few piperidine derivatives were identified as CBSIs. In this regard, we focussed efforts on the piperidi...
Autores principales: | Fu, Dong-Jun, Liu, Si-Meng, Yang, Jia-Jia, Li, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646549/ https://www.ncbi.nlm.nih.gov/pubmed/32588683 http://dx.doi.org/10.1080/14756366.2020.1783664 |
Ejemplares similares
-
Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors
por: Fu, Dong-Jun, et al.
Publicado: (2020) -
Effect of SIRT1 Gene on Epithelial-Mesenchymal Transition of Human Prostate Cancer PC-3 Cells
por: Cui, Ying, et al.
Publicado: (2016) -
MLPH Accelerates the Epithelial–Mesenchymal Transition in Prostate Cancer
por: Zhang, Tianbiao, et al.
Publicado: (2020) -
Effect of Colchicine
Binding Site Inhibitors on the
Tubulin Intersubunit Interaction
por: Sargsyan, Arsen, et al.
Publicado: (2023) -
Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells
por: Qiu, Jia-Xuan, et al.
Publicado: (2015)